Filter Results:
(207)
Show Results For
- All HBS Web
(324)
- People (1)
- News (58)
- Research (207)
- Events (1)
- Multimedia (1)
- Faculty Publications (96)
Show Results For
- All HBS Web
(324)
- People (1)
- News (58)
- Research (207)
- Events (1)
- Multimedia (1)
- Faculty Publications (96)
Sort by
- 12 May 2009
- First Look
First Look: May 12, 2009
work together to achieve better results and include the recipients in the process? Purchase this note: http://hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=909406 Generation Investment Management Harvard Business School Case 609-057... View Details
Keywords: Martha Lagace
- 19 Apr 2004
- Research & Ideas
Birth of the American Salesman
Electric, and Carnegie Steel were all founded in the 1880s; in the following decade came Wrigley's Chewing Gum, General Electric, Burroughs, and Pepsico. These companies developed modern sales techniques, created procedures for management... View Details
Keywords: by Laura Linard
- 24 Jul 2018
- First Look
New Research and Ideas, July 24, 2018
case:https://hbsp.harvard.edu/product/118054-PDF-ENG Harvard Business School Case 318-108 Hikma Pharmaceuticals Governance Journey The case opens with Said Darwazah, chairman and CEO of Hikma Pharmaceuticals, the multinational View Details
Keywords: Dina Gerdeman
- 09 Feb 2016
- First Look
February 9, 2016
land, people, and capital between urban and rural, the new urbanization does not upend China’s longstanding duality between those categories. The central goals of the new urbanization are to manage urbanization so as to generate domestic... View Details
Keywords: Sean Silverthorne
- 01 Feb 2022
- Book
Innovation Isn’t Just for Startups: How Big Companies Can Succeed
The EBOs generated revenues that far exceeded the corporation’s acquisitions portfolio in the same period. Carol Kovac led the most successful EBO, IBM Life Sciences. The innovation for this team was to create solutions relevant to a... View Details
Keywords: by Lane Lambert
- 15 Nov 2018
- Book
Can the Global Food Industry Overcome Public Distrust?
JamesBrey Food is the largest segment of the global economy. It is also widely recognized as more critical for human health than any pharmaceutical drug on the planet. But significant changes in the industry are making people lose trust in many institutions involved in... View Details
- 05 Sep 2007
- First Look
First Look: September 5, 2007
value, or derail deals altogether. Consider, for example, the pharmaceutical company that deadlocked with a supplier over the issue of exclusivity in an ingredient purchase. Believing it was a ploy to raise the price, the drug maker upped... View Details
Keywords: Martha Lagace
- 10 Apr 2014
- Research & Ideas
John Kotter’s Plan to Accelerate Your Business
other more rational. In a typical organization—from the federal government to a pharmaceutical giant—a hierarchical operational structure meets daily demands through clear reporting relationships and responsibilities, Kotter writes. This... View Details
Keywords: by Kim Girard
- 28 Jul 2008
- Research & Ideas
Making the Decision to Franchise (or not)
appears to be true when you get a new type of consumer for the same product." In the pharmaceutical industry, for example, selling medicine to both an independent general practitioner and a hospital will... View Details
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- 03 Sep 2013
- First Look
First Look: September 3
run ads on their blogs and receive 50% of the revenue generated by these ads. After analyzing 4.4 million blog posts, we find that, relative to nonparticipants, popular content increases by about 13 percentage points on participants'... View Details
Keywords: Sean Silverthorne
- 12 Nov 2013
- First Look
First Look: November 12
GlaxoSmithKline: Sourcing Complex Professional Services Pharmaceutical company GlaxoSmithKline (GSK) uses an innovative new approach to procuring outside legal counsel: it replaces relationship-based selection and law firms' traditional... View Details
Keywords: Sean Silverthorne
- 25 Feb 2014
- First Look
First Look: February 25
Laboratories' Proposed Merger with King Pharmaceutical Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives.... View Details
Keywords: Sean Silverthorne
- 15 Dec 2003
- Research & Ideas
The New Global Business Manager
the general manager—the division head, or the CEO. We used to always talk about the CEO as being the grand strategic architect, sitting on top of the company and defining the priorities and making the strategic investments. Historically,... View Details
Keywords: by Cynthia Churchwell
- 20 Oct 2011
- Research & Ideas
Getting the Marketing Mix Right
what is called the Invariant Proportion of Substitution (IPS) property, which implies that the proportion of demand generated by taking business away from a competitor is the same, no matter which marketing activity is used. "These... View Details
Keywords: by Dina Gerdeman
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
fulfillment that uses centralized inventory management. We ask whether, and if so, how, showrooms benefit the two most basic retail objectives: demand generation and operational efficiency. Using quasi-experimental data on showroom... View Details
Keywords: Sean Silverthorne
- August 2017 (Revised July 2018)
- Case
MannKind Corporation: Take a Deep Breath, This Time Afrezza Will Work
By: Elie Ofek and Amanda Dai
In June 2014, MannKind Corporation announced that after years of development and billions of dollars in expenses, the FDA had finally approved its drug, Afrezza. MannKind would thus be the only company with an inhalable insulin on the market. As an alternative to... View Details
Keywords: Health Care and Treatment; Product Launch; Product Positioning; Marketing Strategy; Adoption; Pharmaceutical Industry
Ofek, Elie, and Amanda Dai. "MannKind Corporation: Take a Deep Breath, This Time Afrezza Will Work." Harvard Business School Case 518-031, August 2017. (Revised July 2018.)
- 12 Jan 2016
- First Look
January 12, 2016
November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing drug surveillance is the process of monitoring the adverse... View Details
Keywords: Carmen Nobel
- 05 May 2015
- First Look
First Look: May 5
causes considerable societal damage, as demonstrated by increasing empirical evidence. Drawing on recent research in moral psychology and behavioral ethics, I examine "moral flexibility," or the common ability to justify one's immoral actions by View Details
Keywords: Carmen Nobel
- 09 Jan 2007
- First Look
First Look: January 9, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707413 Teva Pharmaceutical Industries, Ltd. Harvard Business School Case 707-441 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707441 ... View Details
Keywords: Martha Lagace